Bristol-Myers Squibb(US:BMY) Yahoo Finance·2025-09-19 22:45Group 1 - Bristol-Myers Squibb Company (BMY) is recognized as one of the best stocks for a dividend stock portfolio due to its consistent dividend growth over 16 consecutive years [4] - The company declared a quarterly dividend of $0.62 per share on September 17, maintaining its previous dividend level, resulting in a dividend yield of 5.42% as of September 18 [4] - BMY focuses on developing treatments for various diseases, including cancer and blood disorders, with notable products like Opdivo and Eliquis, and is expanding its pipeline in cell therapy and immunology [2][3] Group 2 - In recent years, BMY has aimed to grow its "Growth Portfolio" by launching new medicines and enhancing its global presence, while also acquiring assets through partnerships [3] - A significant challenge for the company is managing revenue declines from its "Legacy Portfolio" as older drugs face patent expirations and generic competition [3] - To counteract these challenges, BMY prioritizes research and development, builds strategic collaborations, and navigates regulatory and pricing pressures in international markets [3]